QED Therapeutics
A biotechnology company focused on precision medicine for FGFR-driven disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
$260—390m (Dealroom.co estimates Jan 2018.)
Palo Alto California (HQ)
Authorizing premium user...